TREATMENT OF NEURODEGENERATIVE DISEASE

摘要

In some aspects, the invention relates to treatments for peptide aggregation associated with disease states such as neurodegenerative disease, particular ly physiology associated with Alzheimer's Disease, and non-neurodegenerative disease aggregation. Other aspects of the invention also provides a variety of novel assays for screening candidate drugs. Yet another aspects of the prese nt invention also provides a series of compositions useful for treatment of neurological disease as determined from these assays. These compositions can be packaged in kits. Other aspects of the invention also relate to the use o f these compositions for the treatment and/or prevention of patients susceptib le to or exhibiting of a disease characteristic of fibril formation or aberrant protein aggregation.